ADiTx Stock Price

-0.017 (-2.06%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,071,038
Bid Price 0.8105
Ask Price 0.818
News -
Day High 0.8499


52 Week Range


Day Low 0.81
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ADiTx Inc ADTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.017 -2.06% 0.81 19:48:46
Open Price Low Price High Price Close Price Prev Close
0.8101 0.81 0.8499 0.8338 0.827
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,522 1,071,038 $ 0.8315902 $ 890,665 - 0.774 - 6.73
Last Trade Time Type Quantity Stock Price Currency
19:47:58 formt 100 $ 0.81 USD


Draw Mode:

ADiTx Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 35.24M 43.50M 41.44M $ - $ - -1.19 -0.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 46.00k 7.80%

more financials information »

ADiTx News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.971.020.7740.81753083,319,569-0.16-16.49%
1 Month1.921.980.7741.142,294,244-1.11-57.81%
3 Months1.592.720.7741.684,466,502-0.78-49.06%
6 Months2.833.950.7742.183,760,411-2.02-71.38%
1 Year1.976.730.7742.672,942,546-1.16-58.88%
3 Years5.2810.400.7743.132,492,561-4.47-84.66%
5 Years5.2810.400.7743.132,492,561-4.47-84.66%

ADiTx Description

Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.